Form 4 filed by David Matthew T
David Matthew T filed this Form 4 on ATNM (Actinium Pharmaceuticals, Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-16 21:11:10 UTC.
- Accession
- 0001213900-26-110340
- Filer
- CIK 1811612
- Filed
- 2026-10-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ATNM · Actinium Pharmaceuticals, Inc. (CIK 1388320)
- David Matthew T officer (Chief Financial Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-14 | A granted | +250,000 | $0 | 250,000 | D |
| Stock Option (right to purchase) derivative | 2026-10-14 | A granted | +250,000 | $0 | 250,000 | D |